Principal Financial Group Inc. Invests $361,000 in Semler Scientific, Inc. (NASDAQ:SMLR)

Principal Financial Group Inc. bought a new stake in Semler Scientific, Inc. (NASDAQ:SMLR) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 15,343 shares of the company’s stock, valued at approximately $361,000.

Other institutional investors have also added to or reduced their stakes in the company. Shariaportfolio Inc. acquired a new position in Semler Scientific in the 3rd quarter valued at approximately $3,618,000. AQR Capital Management LLC boosted its stake in Semler Scientific by 150.1% during the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after acquiring an additional 84,314 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Semler Scientific by 18.3% during the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after acquiring an additional 19,552 shares in the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in Semler Scientific by 20.6% during the first quarter. Jacobs Levy Equity Management Inc. now owns 98,252 shares of the company’s stock worth $2,870,000 after acquiring an additional 16,777 shares in the last quarter. Finally, Pinnacle Associates Ltd. boosted its stake in Semler Scientific by 83.9% during the third quarter. Pinnacle Associates Ltd. now owns 29,346 shares of the company’s stock worth $691,000 after acquiring an additional 13,392 shares in the last quarter. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the sale, the chief executive officer now owns 60,220 shares in the company, valued at $1,707,237. This represents a 14.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 30.20% of the company’s stock.

Semler Scientific Stock Down 4.2 %

Shares of NASDAQ SMLR opened at $63.65 on Monday. The firm has a market cap of $462.74 million, a PE ratio of 31.05 and a beta of 0.92. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $76.98. The company’s fifty day simple moving average is $32.45 and its 200 day simple moving average is $30.85.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million for the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.